Health·3,536 stories
Many cancer patients turn to biotin supplements hoping to restore hair lost during treatment, but doctors warn the vitamin lacks evidence for benefit and may actually interfere with cancer care. Bioti
Real Madrid midfielder Federico Valverde suffered a cranioencephalic trauma after a heated training clash with teammate Aurélien Tchouaméni, forcing him to miss the upcoming El Clásico. The club opene
A new Lancet study by Columbia researchers shows AI‑generated hallucinations are inflating the number of bogus references in scientific papers, with fabricated citations climbing from 1 in 2,828 paper
A new Loma Linda University study of 40,000 seniors finds that regular egg consumption is linked to a markedly lower risk of Alzheimer’s disease—daily or near‑daily intake cuts risk by up to 27%, whil
Two British passengers evacuated from the hantavirus‑infected MV Hondius are recovering, with one in South Africa and another in the Netherlands, while WHO assesses the outbreak’s public‑health risk a
A new analysis in Science shows that as scientists age they cite older literature and shy away from disruptive research, a pattern that compounds with peer‑review and contrasts with the high‑impact wo
WHO officials say the hantavirus cluster on cruise ship MV Hondius is unlikely to trigger an epidemic, noting limited person‑to‑person spread and effective contact tracing. Five cases, three suspected
The FDA has decided to revisit a rare‑cancer therapy it turned down months earlier, a move that follows fresh accusations of political meddling in its review process. STAT+ and related coverage note t
U.S. health agencies are quietly silencing vaccine research and public messaging, with the CDC halting a COVID‑19 booster study and the FDA suppressing safety data on shingles and COVID shots. At the
The FDA has reversed its stance on Ebvallo, a therapy for a rare blood cancer developed by Pierre Fabre Pharmaceuticals and Atara Biotherapeutics, agreeing that existing trial data may be sufficient f
Entrada Therapeutics’ latest exon‑skipping candidate for Duchenne muscular dystrophy fell short of efficacy expectations in an early‑stage trial, putting its competitive edge at risk as the field fill
Helmholtz Munich’s team, led by Prof Timo D. Müller, engineered a ‘Trojan‑horse’ obesity drug that fuses GLP‑1/GIP signaling with the pan‑PPAR agonist lanifibranor. In mouse experiments the hybrid cut
A year-long Japanese study of 92 people with type 2 diabetes found that GLP-1 drugs like Ozempic produce the strongest weight-loss and blood-sugar results in 'external eaters' — people who overeat bec
A University of Connecticut trial of 66 women over 65 found that combining a testosterone gel with exercise selectively reduced dangerous visceral fat after hip fractures, reversing a typical post-inj
Italian drugmaker Angelini Pharma is acquiring U.S. rare‑disease specialist Catalyst Pharmaceuticals for about $4.1 billion in cash, a 28% premium over recent share prices. The deal gives Angelini a d
A large German twin study finds that IQ is about three‑quarters genetically determined and that genetics explain up to 98% of the link between IQ and adult socioeconomic status. Even twins raised toge
PeaceHealth’s plan to replace its long‑standing Oregon emergency physicians with the national staffing firm ApolloMD sparked a wave of opposition from clinicians, lawmakers and community leaders. Afte
MIT neuroscientists discovered that roughly 30% of synapses in the adult mouse cortex are 'silent synapses' — dormant connections lying in wait until new learning activates them, overturning the long-
Researchers at the University of Edinburgh and the UK Dementia Research Institute have shown that lacunar strokes – which affect about 35,000 Britons each year – stem from the widening of small brain
A worldwide push to map the hidden ‘dark proteome’ has uncovered a trove of tiny mitochondrial proteins that may be key to heart disease. Using ribosome profiling on 80 donor hearts, systems biologist
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.